A recent study published in the Journal of Clinical Medicine examined the temporal relationships and associations between cutaneous manifestations and inflammatory bowel disease (IBD).
“We sought to determine the risks of IBD-related dermatologic diseases before and after the diagnosis of IBD,” explained the study authors.
At diagnosis, IBD associations included atopic dermatitis, erythema nodosum, aphthous stomatitis, polyarteritis nodosa, and cutaneous T-cell lymphoma. After IBD diagnosis, patients developed pyoderma gangrenosum, erythema nodosum, polyarteritis nodosa, hidradenitis suppurativa, psoriasis, rosacea, and aphthous stomatitis.
“This study clarified the associations and temporal relationships between cutaneous manifestations and IBD, highlighting the need for interdisciplinary care in the patient with specific dermatologic diseases presenting with abdominal symptoms, or the IBD patients with cutaneous lesions,” concluded the study authors. –Lisa Kuhns
Reference
Hung YT, Le PH, Kuo CJ, et al. The temporal relationships and associations between cutaneous manifestations and inflammatory bowel disease: a nationwide population-based cohort study. J Clin Med. 2021;10(6):1311. doi:10.3390/jcm10061311
